Speaker illustration

Doctor Davor Vukadinovic

Saarland University Hospital, Homburg (Germany)

Member of:

European Society of Cardiology
Heart Failure Association

Dr Davor Vukadinović attended School of medicine at the University of Belgrade, Serbia. He currently attends his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine at the Saarland University Hospital, Homburg, Germany. The main subject of his scientific interest represent adherence to the cardiovascular pharmacology, novel therapy principles in interventional cardiology and heart failure. He is a member of European Society of Cardiology.

Efficacy and safety aspects of renal denervation in treatment of arterial hypertension: a systematic review and meta-analysis

Event: ESC Congress 2023

Topic: Device Treatment and Intervention

Session: What’s new in hypertension?

Thumbnail

Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Insights from recent HFrEF trials 2

Thumbnail

Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Challenges in hypertension treatment

Thumbnail

Interventional patent foramen ovale closure or medical therapy only for the prevention of recurrent strokes: A meta analysis of available randomized trials

Event: ESC Congress 2018

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Non-coronary cardiac interventions

Thumbnail

True rate of drug-related adverse effects on potassium homeostasis of the renin angiotensin aldosterone system inhibitors in placebo controlled trials: a meta-analysis

Event: ESC Congress 2016

Topic: Pharmacologic therapy

Session: Heart failure / Left ventricular dysfunction

Thumbnail